2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Dong-A St Co., Ltd | 10% Owner | 9,995,679 | May 20, 2025 |
| E&Healthcare Investment Fund No.7 | — | 7,321,789 | Jan 10, 2020 |
| E&Investment, Inc. | — | 3,126,136 | Jul 28, 2022 |
| E&Healthcare Investment Fund II | — | 3,126,136 | Jul 28, 2022 |
| JK BioPharma Solutions, Inc | — | 2,618,012 | Jan 17, 2020 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Jan 27, 2026 | Woodworth Marshall H | CFO | Neutral | 90.0 | +28,000 | 1024.14% | ✗ | - |
| Jan 23, 2026 | Jan 27, 2026 | Kim Hyung Heon | CEO | Neutral | 90.0 | +32,000 | 577.10% | ✗ | - |
| Aug 12, 2025 | Aug 13, 2025 | Woodworth Marshall H | CFO | Neutral | 27.5 | -14,200 | -32.07% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | Glickman Mark A | Director | Neutral | 90.0 | +28,147 | 288.98% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | GROVES JASON L | Director | Neutral | 90.0 | +28,147 | 160.36% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | Tursi James Patrick | Director | Neutral | 90.0 | +28,147 | 310.26% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | STRICKLAND D GORDON | Director | Neutral | 90.0 | +28,147 | 160.36% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | KOVEN ANDREW I | Director | Neutral | 90.0 | +28,147 | 160.36% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | Salsbury Michael | Director | Neutral | 90.0 | +28,147 | 160.36% | ✗ | - |
| Jun 4, 2025 | Jun 4, 2025 | Woodworth Marshall H | CFO | Buy | 90.0 | +14,200 | 47.21% | ✗ | $9.9K |
| May 8, 2025 | May 20, 2025 | DONG-A ST CO., LTD | 10% Owner | Buy | 100.0 | +4,647,887 | 86.91% | ✗ | $3.3M |
| Mar 1, 2025 | Mar 4, 2025 | Woodworth Marshall H | CFO | Sell | 27.5 | -3,417 | -10.20% | ✗ | $5K |
| Mar 1, 2025 | Mar 4, 2025 | Kim Hyung Heon | CEO | Sell | 27.5 | -2,795 | -4.38% | ✗ | $4.1K |
| Nov 30, 2024 | Dec 2, 2024 | Kim Hyung Heon | CEO | Sell | 27.5 | -2,867 | -4.30% | ✗ | $7.3K |
| Sep 12, 2024 | Sep 20, 2024 | DONG-A ST CO., LTD | 10% Owner | Sell | 52.5 | -407 | -0.01% | ✗ | $1.5K |
| Aug 11, 2024 | Aug 13, 2024 | Kim Hyung Heon | CEO | Sell | 26.3 | -11,467 | -14.68% | ✗ | $41.3K |
| Jun 23, 2024 | Jul 10, 2024 | DONG-A ST CO., LTD | 10% Owner | Buy | 100.0 | +2,544,530 | 90.76% | ✗ | $10M |
| Jun 23, 2024 | Jun 25, 2024 | DONG-A ST CO., LTD | 10% Owner | Buy | 100.0 | +2,544,530 | 90.76% | ✗ | $8M |
| Jun 7, 2024 | Jun 7, 2024 | Salsbury Michael | Director | Neutral | 90.0 | +5,051 | 40.40% | ✗ | - |
| Jun 7, 2024 | Jun 7, 2024 | GROVES JASON L | Director | Neutral | 90.0 | +5,051 | 40.40% | ✗ | - |
| Jun 7, 2024 | Jun 7, 2024 | KOVEN ANDREW I | Director | Neutral | 90.0 | +5,051 | 40.40% | ✗ | - |
| Jun 7, 2024 | Jun 7, 2024 | Glickman Mark A | Director | Neutral | 90.0 | +5,051 | 107.72% | ✗ | - |
| Jun 7, 2024 | Jun 7, 2024 | STRICKLAND D GORDON | Director | Neutral | 90.0 | +5,051 | 40.40% | ✗ | - |
| Jun 7, 2024 | Jun 7, 2024 | Tursi James Patrick | Director | Neutral | 90.0 | +5,051 | 125.62% | ✗ | - |
| Mar 1, 2024 | Mar 4, 2024 | Woodworth Marshall H | CFO | Neutral | 90.0 | +33,496 | 100.00% | ✗ | - |
| Dec 1, 2023 | Dec 4, 2023 | Tursi James Patrick | Director | Neutral | 90.0 | +32,157 | 100.00% | ✗ | - |
| Nov 2, 2023 | Tursi James Patrick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 30, 2023 | Woodworth Marshall H | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 11, 2023 | Aug 14, 2023 | Kim Hyung Heon | CEO | Neutral | 90.0 | +625,064 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | KOVEN ANDREW I | Director | Neutral | 90.0 | +100,000 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | Salsbury Michael | Director | Neutral | 90.0 | +100,000 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | STRICKLAND D GORDON | Director | Neutral | 90.0 | +100,000 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | GROVES JASON L | Director | Neutral | 90.0 | +100,000 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | Glickman Mark A | Director | Neutral | 90.0 | +37,500 | 100.00% | ✗ | - |
| Jul 27, 2023 | Jul 28, 2023 | Kim Na Yeon | Director | Neutral | 90.0 | +100,000 | 49.50% | ✗ | - |
| Jul 26, 2022 | Jul 28, 2023 | Kim Na Yeon | Director | Neutral | 90.0 | +4,671 | 100.00% | ✗ | - |
| May 12, 2023 | Glickman Mark A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 18, 2023 | Hooker Joseph | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 22, 2022 | GOLDMAN SACHS GROUP INC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 26, 2022 | Jul 28, 2022 | E&Investment, Inc. | 10% Owner | Neutral | 27.5 | -1,445,267 | -19.37% | ✗ | - |
| Jul 26, 2022 | Jul 28, 2022 | Kim Na Yeon | Director | Neutral | 27.5 | -1,445,267 | -19.62% | ✗ | - |
| Jun 9, 2022 | Jun 13, 2022 | Kim Na Yeon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 13, 2022 | GROVES JASON L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Kim Hyung Heon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Kang Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | STRICKLAND D GORDON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | Salsbury Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 10, 2022 | KOVEN ANDREW I | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 27, 2022 | Feb 2, 2022 | STRICKLAND D GORDON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 2, 2022 | STRICKLAND D GORDON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 3, 2021 | Nov 4, 2021 | Price Ben Gil | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 4, 2021 | Price Ben Gil | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 2, 2021 | Sep 3, 2021 | KOVEN ANDREW I | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 19, 2021 | Kim Hyung Heon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 19, 2021 | KOVEN ANDREW I | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 31, 2020 | Jan 5, 2021 | Bakshi Akash | COO | Neutral | 90.0 | +884,072 | 3047.16% | ✗ | - |
| Jan 5, 2021 | Bakshi Akash | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 1, 2020 | Sep 3, 2020 | Swirsky Douglas J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 3, 2020 | Swirsky Douglas J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 17, 2020 | JK BioPharma Solutions, Inc | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 13, 2020 | Jan 15, 2020 | Salsbury Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2020 | Jan 15, 2020 | Oh Jeong Gyun | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2020 | Jan 15, 2020 | Kim Na Yeon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2020 | Jan 15, 2020 | Jeong Tae Heum | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2020 | Jan 15, 2020 | Gullans Steven R. Ph.D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2020 | Jan 15, 2020 | GROVES JASON L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 10, 2020 | E&Investment, Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 9, 2020 | JK BioPharma Solutions, Inc | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 9, 2020 | E&Investment, Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 9, 2020 | DONG-A ST CO., LTD | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | Jan 2, 2020 | Versavel Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 30, 2019 | Jan 2, 2020 | Oh Jeong Gyun | Director | Neutral | 90.0 | +2,057,893 | 100.00% | ✗ | - |
| Dec 30, 2019 | Jan 2, 2020 | Kim Na Yeon | Director | Neutral | 90.0 | +7,321,789 | 100.00% | ✗ | - |
| Jan 2, 2020 | Oh Jeong Gyun | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Kim Na Yeon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Kang Jeong Gu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | Shannon Nicola | VP, Clinical Operations | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | Versavel Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | Salsbury Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | GROVES JASON L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 30, 2019 | Jeong Tae Heum | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 24, 2019 | Jul 26, 2019 | SASSINE ANDY | Director | Neutral | 90.0 | +15,000 | 11.01% | ✗ | - |
| Jul 24, 2019 | Jul 26, 2019 | LICHTINGER PEDRO | Director | Neutral | 90.0 | +15,000 | 25.07% | ✗ | - |
| Jul 24, 2019 | Jul 26, 2019 | KOUSKY KENNETH W | Director | Neutral | 90.0 | +15,000 | 125.68% | ✗ | - |
| Jul 24, 2019 | Jul 26, 2019 | Reno Seth | Chief Commercial Officer | Neutral | 90.0 | +100,000 | 546.87% | ✗ | - |
| Jul 24, 2019 | Jul 26, 2019 | Bisgaier Charles PhD | Chair | Neutral | 85.0 | +100,000 | 7.41% | ✗ | - |
| Jul 24, 2019 | Jul 26, 2019 | Gullans Steven R. Ph.D. | CEO | Neutral | 90.0 | +300,000 | 100.00% | ✗ | - |
| May 22, 2018 | May 24, 2018 | Gullans Steven R. Ph.D. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 1, 2018 | May 3, 2018 | Gullans Steven R. Ph.D. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2018 | Feb 12, 2018 | Reno Seth | Chief Commercial Officer | Buy | 95.0 | +14,286 | 357.15% | ✗ | $100K |
| Feb 8, 2018 | Feb 12, 2018 | Gullans Steven R. Ph.D. | CEO | Buy | 92.5 | +71,429 | 8.32% | ✗ | $500K |
| Jan 29, 2018 | Jan 30, 2018 | SASSINE ANDY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 29, 2018 | Jan 30, 2018 | LICHTINGER PEDRO | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 29, 2018 | Jan 30, 2018 | KOUSKY KENNETH W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 29, 2018 | Jan 30, 2018 | Hawryluk P. Kent | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2018 | Jan 30, 2018 | Bisgaier Charles PhD | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2018 | Jan 30, 2018 | Golden Lee Scott | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2018 | Jan 30, 2018 | MATHIESEN JEFFREY S | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2018 | Jan 30, 2018 | Reno Seth | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 29, 2018 | Jan 30, 2018 | Gullans Steven R. Ph.D. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |